We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Tango Therapeutics
TNGX
$4.34B
| $18.9K | ﹤0.01% |
904
-121
| -12% | -$1.68K |
|
1977
Kodiak Sciences
KOD
$2.59B
| $18.9K | ﹤0.01% |
+496
| New | +$12.8K |
|
1978
Nuvation Bio
NUVB
$2.24B
| $18.8K | ﹤0.01% |
4,371
+1,043
| +31% | +$5.81K |
|
1979
Castle Biosciences
CSTL
$749M
| $18.7K | ﹤0.01% |
761
-1,078
| -59% | -$35.3K |
|
1980
Boston Beer
SAM
$1.88B
| $18.7K | ﹤0.01% |
81
+19
| +31% | +$4.27K |
|
|
TIC
1981
TIC Solutions Inc
TIC
$1.58B
| $18.6K | ﹤0.01% |
2,828
+675
| +31% | +$6.35K |
|
1982
Evertec
EVTC
$1.83B
| $18.5K | ﹤0.01% |
657
-92,796
| -99% | -$2.64M |
|
|
SEZL
1983
Sezzle
SEZL
$5.17B
| $18.5K | ﹤0.01% |
292
+47
| +19% | +$3.2K |
|
1984
Enovix
ENVX
$862M
| $18.5K | ﹤0.01% |
3,567
+1,074
| +43% | +$6.72K |
|
1985
Theravance Biopharma
TBPH
$874M
| $18.4K | ﹤0.01% |
+1,136
| New | +$20.1K |
|
1986
Redwire
RDW
$2.08B
| $18.4K | ﹤0.01% |
2,161
+750
| +53% | +$7.35K |
|
1987
Healthcare Services Group
HCSG
$1.56B
| $18.3K | ﹤0.01% |
985
+127
| +15% | +$2.51K |
|
|
RAPP
1988
Rapport Therapeutics
RAPP
$1.95B
| $18.2K | ﹤0.01% |
582
+162
| +39% | +$4.56K |
|
1989
Freshworks
FRSH
$2.84B
| $18.2K | ﹤0.01% |
2,266
+249
| +12% | +$2.3K |
|
1990
Clear Channel Outdoor Holdings
CCO
$1.23B
| $18.2K | ﹤0.01% |
7,670
+2,140
| +39% | +$4.84K |
|
1991
Matthews International
MATW
$864M
| $18.1K | ﹤0.01% |
701
+253
| +56% | +$6.63K |
|
1992
Xeris Biopharma Holdings
XERS
$1.44B
| $18K | ﹤0.01% |
3,105
+752
| +32% | +$4.99K |
|
1993
PagerDuty
PD
$700M
| $17.9K | ﹤0.01% |
2,885
-10,544
| -79% | -$91.2K |
|
1994
Center Bancorp
CNOB
$1.63B
| $17.7K | ﹤0.01% |
662
+96
| +17% | +$2.58K |
|
1995
Under Armour
UAA
$3B
| $17.5K | ﹤0.01% |
2,965
-896
| -23% | -$5.81K |
|
1996
CRA International
CRAI
$1.1B
| $17.5K | ﹤0.01% |
108
+20
| +23% | +$3.61K |
|
1997
Goosehead Insurance
GSHD
$1.39B
| $17.4K | ﹤0.01% |
+408
| New | +$22.8K |
|
1998
Stock Yards Bancorp
SYBT
$2.41B
| $17.4K | ﹤0.01% |
262
-8
| -3% | -$533 |
|
1999
Papa John's
PZZA
$999M
| $17.3K | ﹤0.01% |
534
+103
| +24% | +$3.58K |
|
2000
MoonLake Immunotherapeutics
MLTX
$1.59B
| $17.2K | ﹤0.01% |
923
-61,025
| -99% | -$1.01M |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.